 |
|
|
| |
Improvement of hepatic fibrosis in patients with non-alcoholic steatohepatitis treated with selonsertib is associated with improvement of patient-reported outcomes
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-23, Amsterdam, Netherlands
Zobair M. Younossi1,2, Maria Stepanova3, Zachary Goodman1, Eric Lawitz4, Michael Charlton5, Rohit Loomba6, Sharon Hunt3
1. Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA
2. Beatty Liver and Obesity Research Program, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA
3. Center for Outcomes Research in Liver Diseases, Washington DC, USA
4. Texas Liver Institute, University of Texas Health, San Antonio, TX, USA
5. Intermountain Medical Center, Salt Lake City, UT, USA
6. University of California in San Diego, La Jolla, CA, USA
|
| |
|
|
|
|
|
